| Dramatically improved survival in multiple myeloma patients in the recent decade: results from a Swedish population-based study S Thorsteinsdottir, PW Dickman, O Landgren, C Blimark, M Hultcrantz, ... Haematologica 103 (9), e412, 2018 | 114 | 2018 |
| Pathogenesis and biomarkers of carcinogenesis in ulcerative colitis S Thorsteinsdottir, T Gudjonsson, OH Nielsen, B Vainer, JB Seidelin Nature reviews Gastroenterology & hepatology 8 (7), 395-404, 2011 | 103 | 2011 |
| Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized … S Rögnvaldsson, TJ Love, S Thorsteinsdottir, ER Reed, JÞ Óskarsson, ... Blood Cancer Journal 11 (5), 94, 2021 | 65 | 2021 |
| Fractures and survival in multiple myeloma: results from a population-based study S Thorsteinsdottir, G Gislason, T Aspelund, I Sverrisdottir, O Landgren, ... Haematologica 105 (4), 1067, 2020 | 42 | 2020 |
| Bone disease in monoclonal gammopathy of undetermined significance: results from a screened population-based study S Thorsteinsdottir, SH Lund, EK Lindqvist, M Thordardottir, G Sigurdsson, ... Blood advances 1 (27), 2790-2798, 2017 | 36 | 2017 |
| Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: results of the iStopMM study TE Long, OS Indridason, R Palsson, S Rognvaldsson, TJ Love, ... Blood Cancer Journal 12 (9), 133, 2022 | 35 | 2022 |
| Prevalence of smoldering multiple myeloma based on nationwide screening S Thorsteinsdóttir, GK Gíslason, T Aspelund, S Rögnvaldsson, ... Nature medicine 29 (2), 467-472, 2023 | 25 | 2023 |
| Comorbidities in multiple myeloma and implications on survival: A population‐based study IS Sverrisdóttir, S Rögnvaldsson, S Thorsteinsdottir, GK Gíslason, ... European journal of haematology 106 (6), 774-782, 2021 | 22 | 2021 |
| Screening for monoclonal gammopathy of undetermined significance: a population-based randomized clinical trial. First results from the Iceland Screens, Treats, or Prevents … SY Kristinsson, S Rögnvaldsson, S Thorsteinsdottir, ER Reed, ... Blood 138, 156, 2021 | 17 | 2021 |
| Prevalence of MGUS is high in the istopmm study but the prevalence of IgA MGUS does not increase with age in the way other immunoglobulin subtypes do TJ Love, S Rögnvaldsson, S Thorsteinsdottir, T Aspelund, ER Reed, ... Blood 140 (Supplement 1), 256-258, 2022 | 9 | 2022 |
| Prevalence of smoldering multiple myeloma: results from the Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) study S Thorsteinsdottir, GK Gislason, T Aspelund, S Rögnvaldsson, ... Blood 138 (Supplement 1), 151-151, 2021 | 8 | 2021 |
| Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study S Rognvaldsson, E Eythorsson, S Thorsteinsdottir, B Vidarsson, ... Blood Cancer Journal 11 (12), 191, 2021 | 7 | 2021 |
| Myeloproliferative neoplasms in five multiple sclerosis patients S Thorsteinsdottir, OW Bjerrum, HC Hasselbalch Leukemia Research Reports 2 (2), 61-63, 2013 | 7 | 2013 |
| The consultant's guide to smoldering multiple myeloma S Thorsteinsdottir, SY Kristinsson Hematology 2022 (1), 551-559, 2022 | 5 | 2022 |
| The first wave of COVID‐19 and concurrent social restrictions were not associated with a negative impact on mental health and psychiatric well‐being TJ Love, I Wessman, GK Gislason, S Rognvaldsson, S Thorsteinsdottir, ... Journal of Internal Medicine 291 (6), 837-848, 2022 | 5 | 2022 |
| Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized … S Rögnvaldsson, TJ Love, S Thorsteinsdottir, ER Reed, JÞ Óskarsson, ... | 5 | |
| Validity of chronic disease diagnoses in Icelandic healthcare registries S Rögnvaldsson, TE Long, S Thorsteinsdottir, TJ Love, SY Kristinsson Scandinavian Journal of Public Health 51 (2), 173-178, 2023 | 4 | 2023 |
| Autoimmune diseases are not associated with monoclonal gammopathy of undetermined significance: results of the prospective population-based Istopmm study IS Sverrisdottir, S Thorsteinsdóttir, S Rögnvaldsson, T Aspelund, ... Blood 140 (Supplement 1), 10031-10032, 2022 | 4 | 2022 |
| Defining new reference intervals for serum free light chains in individuals with reduced kidney function: results of the population-based on iceland screens treats or prevents … T Einarsson Long, OS Indridason, R Palsson, S Rögnvaldsson, TJ Love, ... Blood 138 (Supplement 1), 542-542, 2021 | 4 | 2021 |
| Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study AÝ Sigurbergsdóttir, S Rögnvaldsson, S Thorsteinsdóttir, I Sverrisdóttir, ... Haematologica 108 (12), 3392, 2023 | 3 | 2023 |
